AP lifestyles reporter explains the origins, benefits of chair yoga and its surge in popularity
In this episode of 'The Story Behind the AP Story,' Italie explains the origins of chair yoga, its benefits and how it works.
Haya Panjwani, host: Hi, I'm Haya Panjwani, and I'm the host of 'The Story Behind the AP Story.' Today we're joined by Leanne Italie, a lifestyles reporter for The Associated Press. Hi, Leanne. How are you doing?
ARTICLE CONTINUES BELOW
Leanne Italie, AP lifestyles reporter: I'm great. How are you?
PANJWANI: I'm great. Thank you for asking. Today we're going to talk about chair yoga. What is it?
ITALIE: Yeah, sure, so chair yoga has a really sort of interesting and important history. Traditional yoga done on the floor on mats is over 5,000 years old, but chair yoga is a relatively new offshoot.
In 1982, a yoga instructor named Lakshmi Voelker noticed that a student of hers in a traditional yoga class who was in her 30s and suffered from arthritis was having trouble getting down on the floor. So, Voelker decided to adapt some poses for use in a chair. And she has since sort of become the guru of chair yoga, and she has written, since co-written a book about it.
Chair yoga has really gone a long way in boosting the accessibility of yoga itself to many age groups, including older people and people who have physical limitations.
PANJWANI: Are there any communities that benefit from chair yoga in particular?
ITALIE: Absolutely. I mean, chair yoga is great for anybody who wants a gentle workout, but it's not easy, and there are many, many benefits. So, obviously, it has a lot to offer older people, particularly older women who are prone to osteoporosis, and it's a gentle and safe way to improve your flexibility, your strength and your balance. It helps minimize the risk of falls and fractures.
There's not a body part that it really doesn't help. It helps the spine, the hips, the legs, all engaged. It also helps your core, helps you strengthen your core and your back, and it can help manage stiffness and pain associated with a lot of conditions, including arthritis and osteoporosis. It's not difficult to adapt traditional yoga poses for a chair, which I found kind of surprising, because, you know, yoga looks so daunting sometimes, and there are so many — there's a spiritual aspect to yoga that a lot of people don't realize, you know, in the West. You know, in addition to all the physical benefits, you know, there are relaxation benefits there's, you know, stress management benefits, like from the breathing and the mindfulness aspect of yoga. So, all of that can be adapted to a chair as well.
ARTICLE CONTINUES BELOW
ARTICLE CONTINUES BELOW
PANJWANI: How is chair yoga linked to better well-being or fall prevention?
ITALIE: Yeah, I mean, while there's a lot of research on regular traditional yoga, there is some research that breaks out chair yoga in particular. One study from 2012 found that 15 minutes of chair yoga significantly improves physical and psychological markers for stress. And then another study in the April 2023 journal Healthcare indicates that chair yoga went a long way to counter knee osteoarthritis in women 65 and older. There are other benefits, too, like for instance, office workers who spend a lot of time hunched over screens can just do chair yoga right there in their chair at their desks, and that can really improve posture.
PANJWANI: Your story talks about the divide between men and women who do yoga. Why is that?
ITALIE: I find this really, really interesting, and in the story that we did on chair yoga, we asked some longtime yoga participants, practitioners, what they thought — some women in their 70s and their 80s who've been doing yoga for 40, 50 years, why are there not more men in your classes? And they said, well, there's no one definitive answer here, and there's no way to avoid a massive generalization on who men are as a group. But, you know, so you do get different answers depending on who you ask. But, data from the U.S. Centers for Disease Control and Prevention do show that women are more than twice as likely as men to practice yoga.
You know, ancient yoga over the many thousands of years was exclusively reserved for men. And then it became popular in Western culture in the 1960s and '70s as part of sort of the hippie counterculture movement and the New Age movement. And marketing started to skew to women in the '80s and '90s. And that sort of was an outgrowth of the growing fitness industry in the West and the rise of workouts like on VHS tapes and DVDs that people could do at home.
PANJWANI: Thank you for listening to 'The Story Behind the AP Story.' To listen to previous episodes, visit apnews.com.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Toronto Star
4 hours ago
- Toronto Star
Sarepta will resume gene therapy shipments after FDA review of recent patient death
WASHINGTON (AP) — Shares of beleaguered drugmaker Sarepta Therapeutics jumped in afterhours trading Monday after the company said it would resume shipping its gene therapy for some patients, following a brief pause requested by regulators. The Food and Drug Administration said it recommended lifting the hold for young patients with Duchenne's muscular dystrophy who are still able to walk. Regulators had requested the pause after the deaths of two older teenagers who were taking the therapy. The FDA also said in a statement it determined that a recently reported death of an 8-year-old boy was unrelated to the therapy.
Winnipeg Free Press
5 hours ago
- Winnipeg Free Press
Sarepta will resume gene therapy shipments after FDA review of recent patient death
WASHINGTON (AP) — Shares of beleaguered drugmaker Sarepta Therapeutics jumped in afterhours trading Monday after the company said it would resume shipping its gene therapy for some patients, following a brief pause requested by regulators. The Food and Drug Administration said it recommended lifting the hold for young patients with Duchenne's muscular dystrophy who are still able to walk. Regulators had requested the pause after the deaths of two older teenagers who were taking the therapy. The FDA also said in a statement it determined that a recently reported death of an 8-year-old boy was unrelated to the therapy. Company shares surged more than 16% after the announcement to $13.86 in afterhours trading. The jump is the latest in a series of drastic stock movements triggered by changing fortunes for the company's best-selling product. Elevidys is the first gene therapy approved in the U.S. for Duchenne's muscular dystrophy, the fatal muscle-wasting disease that affects boys and young men, resulting in early death. It received accelerated approval in 2023 for a narrow range of young patients and was expanded last year for use in older patients, including those who can no longer walk. The FDA decision Monday 'significantly improves Elevidys' sales outlook in the near-term,' Jefferies analyst Andrew Tsai told investors, in a note after the announcement. 'The street will feel relieved about the situation, suggesting meaningful stock upside potential.' Sarepta's therapy has been under scrutiny from regulators after two teenage boys died earlier this year from acute liver injury, a known side effect of the treatment. The FDA then requested a pause in shipments of the drug after the death of a third patient taking a different Sarepta therapy. FDA officials have suggested the company will need to provide new study data on safety to resume Elevidys' use in older patients. 'The FDA will continue to work with the sponsor regarding non-ambulatory patients, which remains subject to a voluntary hold, following two deaths,' FDA said in its statement. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Winnipeg Free Press
7 hours ago
- Winnipeg Free Press
Clemson's Dabo Swinney rooting for Hunter Renfrow as he attempts NFL comeback with Panthers
CHARLOTTE, N.C. (AP) — Hunter Renfrow remembers being cut by the Las Vegas Raiders on March 13, 2024, and not even caring all that much. He had no desire to play football. Physically, he felt awful. He'd lost 35 pounds, went a week with a 103-degree fever and was completely zapped of the energy and fire he was once known to bring to the football field. Running routes, catching passes and being blasted by defensive backs was the last thing on his mind. But after being diagnosed with a severe case of ulcerative colitis, a chronic inflammatory bowel disease that causes inflammation and ulcers in the lining of the large intestine and rectum, the 2021 Pro Bowler is now feeling like himself again. He's trying to make an NFL comeback with the Carolina Panthers, the team he rooted for as a kid growing up in Myrtle Beach, South Carolina. Dabo Swinney, his college coach at Clemson, believes if anyone can make it back it's Renfrow. 'You're playing football at the highest level and he just couldn't eat,' Swinney said. 'It affected him, and he was really done (with football). I didn't think he was gonna play again.' Neither did Renfrow. 'I was like, I'm never playing a football again,' Renfroe said. 'Like when you feel like that, you feel like you're letting your teammates down.' Renfrow's problems surfaced late in the 2021 season in which he caught a career-high 103 passes for 1,038 yards and nine touchdowns. He noticed his energy level had dropped off significantly and he could never seem to get it all the way back, even after taking a month off to prep for his first Pro Bowl appearance. The Raiders rewarded Renfrow with a two-year, $32 million contract extension that offseason, but he never came close to reaching that level of production again. He caught just 36 passes for 330 yards and two touchdowns in 2022 and 25 passes for 255 yards and no touchdowns in 2023, leading to his release. But after several hospital visits and a referral to a Charlotte-area pediatrician, Renfrow finally received a diagnosis. He began receiving treatment, started a new diet and saw his appetite return. By September he'd put back on the 35 pounds he'd lost and then some. His energy returned. He played pickleball, basketball and golf and the competitive juices began to return. As the 2024 NFL season went out without him, Renfrow privately began discussing a possible comeback with Swinney, who has remained a close friend and father figure. 'I was like Hunter, listen, you know you're gonna be 40 one day,' Swinney said. 'So if you got more left in you …' In January, Renfrow took Swinney's advice and began to work his way back into football shape. He asked his agent if the Panthers might be interested in giving him a workout. They were, and that ultimately led to a one-year, $1.22 million contract that included a modest $50,000 signing bonus. It was a no-lose proposition for the Panthers. But if Monday is any indication, Renfrow might just be a solid under-the-radar free agent addition for the Panthers. With Swinney observing from the Panthers sideline as a guest of coach Dave Canales, the 5-foot-10 Renfrow made two impressive catches reminiscent of the player who went from walk-on to catching the game-winning touchdown pass with 1 second remaining in Clemson's dramatic 35-31 win over Alabama in the national championship game in the 2016 season. Renfrow said he feels appreciative as he continues 'pushing toward something special.' While the unimposing Renfrow may look like an ordinary guy off the field, Swinney said that when he puts on the pads he 'turns into Superman.' 'He catches it. He makes plays,' Swinney said. 'He understands the leverage and influence and route-running and break points and how to set things up and how to play with his hands at full speed. And he's just got elite change of direction. … But he's a little guy that plays really big, and is really crafty. Just his ability to separate and change direction, that's hard to find.' Renfrow is no lock to make the Panthers roster. The Panthers have upgraded their wide receiver position in recent years, drafting Xavier Legette and Tetairoa McMillan in the first round in 2024 and 2025, respectively. They also have veteran wide receivers Adam Thielen and David Moore, and the team remains high on last year's surprise undrafted rookie standout Jalen Coker. But Canales likes what he's seen so far from Renfrow. 'He looks like the Hunter that I remember,' Canales said. Canales said Renfrow began to show a burst during the team's OTAs in the spring, and he's been pleased with his development ever since, citing the five-year NFL veteran's knowledge of coverages and leverages and ability to attack defenses. Thursdays Keep up to date on sports with Mike McIntyre's weekly newsletter. The next month will go a long way toward determining whether Renfrow is able to make it all the way back. Either way, at least he has his health. 'I'm just pulling for him,' Swinney said. 'He's having fun again. He's 29 and so I'm just happy that he's back out here. If he stays healthy he'll do what Renfrow does. That's just who he is.' ___ AP NFL:
